Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering

Multiple myeloma (MM) remains an incurable hematological neoplasm. Neoantigen-specific T cell receptor (TCR)-engineered T (TCR-T) cell therapy is a potential alternative treatment. Particularly, TCRs derived from a third-party donor may cover broad ranges of neoantigens, whereas TCRs in patients suf...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Masahiro, Shimizu, Kanako, Nakazato, Hiroshi, Yamasaki, Satoru, Fujii, Shin-ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285226/
https://www.ncbi.nlm.nih.gov/pubmed/37359417
http://dx.doi.org/10.1016/j.omtm.2023.05.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285226/
https://www.ncbi.nlm.nih.gov/pubmed/37359417
http://dx.doi.org/10.1016/j.omtm.2023.05.014

Ejemplares similares